Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market in 2025: Innovations In Benign Prostatic Hyperplasia (BPH) Treatment

How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%. Factors such as an aging population, increased awareness and diagnosis, improved access to healthcare, and personalized treatments have contributed to this growth in the historic period.

Expectations are high for notable expansion in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in the coming years. The market is projected to swell to $1.8 billion by 2029, propelled by a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this anticipated growth during the forecast period include the increase in minimally invasive techniques, the expansion of emerging markets, robust regulatory support, and the structure of value-based healthcare. Key trends likely to shape this market in the future include the rise of non-surgical and office-based procedures, the adoption of laser and radiofrequency technologies, the growth in telemedicine and remote consultation, as well as an increase in patient education and engagement.

What Are the Primary Growth Drivers for the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
The growth of the benign prostatic hyperplasia market is expected to be driven by the rise in prostate cancer incidences. Prostate cancer is a type of cancer that stems from the prostate gland, a small gland just beneath the male bladder that resembles a walnut in size. Increased prostate cancer cases typically result in more elderly men seeking medical help for prostate-related concerns. This ultimately leads to the detection and treatment of benign prostatic hyperplasia. For example, in February 2023, the American Society of Clinical Oncology (ASCO), a professional organization based in the US that provides patient information on cancer.net, recorded an estimated 288,300 men diagnosed with prostate cancer in 2023. In addition, they reported 268,490 new cases and 34,500 prostate cancer deaths in 2022. Consequently, the rise in prostate cancer incidences is fuelling the expansion of the benign prostatic hyperplasia market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp

Who Are the Dominant Companies Influencing Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Trends?
Major companies operating in the benign prostatic hyperplasia (BPH) treatment devices and equipment market include Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston scientific Inc., Endo International plc, NeoTract Inc., OmniGuide Inc., Medifocus Inc., ProArc Medical Ltd., Teleflex Incorporated, Medtronic plc, Urotech Devices, Prostalund Operations AB, Baxter International, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Siemens Healthineers, Quest Pharmatech, Protox Therapeutics, IntelGenx Technologies Corp, Astellas Pharma Inc., Ipsen S.A., Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, Merit Medical Systems, Pnn Medical A/S, PROCEPT BioRobotics, Prosenex, ProSolv CardioVascular Inc., Quanta System, Rocamed SAM, RZ Medizintechnik GmbH, SRS Medical Systems, UroShape LLC, Vertebron Inc.

How Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Evolving?
Major firms active in the benign prostatic hyperplasia market are emphasizing the creation of innovative merchandise, including the UroLift 2 System and the UroLift ATC advanced tissue control system, offering dependable services to consumers. These systems are released for treating lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). In May 2022, for example, Teleflex Incorporated, a medical device company based in the US, introduced the UroLift 2 System and UroLift ATC. The UroLift 2 System is engineered to reach the prostatic urethra and implant permanent UroLift through the prostate lobes, whereas the UroLift ATC advanced tissue control system exercises a minimally invasive method to alleviate symptoms of prostate enlargement. This represents a progressive strategy in managing benign prostatic hyperplasia (BPH), by lifting and securing the enlarged prostate tissue to prevent it from obstructing the urethra.

What Are the Different Segmentations in the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
The benign prostatic hyperplasia (BPH) treatment devices and equipment market covered in this report is segmented -

1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types
3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home

Subsegments:
1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes
2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation
3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers
4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents
5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Which Region Is at the Forefront of the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2023. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (BNH) treatment devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

What Is Covered In The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report?

- Market Size Analysis: Analyze the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2431

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.